FIRST MANHATTAN CO. LLC. - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 2 filers reported holding VYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3832,5570.0%0.00%
Q3 2022$02,5570.0%0.00%
Q2 2022$0
-100.0%
2,5570.0%0.00%
Q1 2022$1,000
-50.0%
2,5570.0%0.00%
Q4 2021$2,000
-33.3%
2,5570.0%0.00%
Q3 2021$3,000
-83.3%
2,557
-52.0%
0.00%
Q2 2021$18,000
-50.0%
5,3290.0%0.00%
Q1 2021$36,0005,3290.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders